Mary Woolley's Weekly Letter: Delays Hurt Us All

By Mary Woolley on January 31, 2019
Dear Research Advocate: As you know, there has been a cease fire in the shutdown and people are back to work, at least for now. Over the next two weeks, members of Congress will attempt to resolve the stalemate over funding for the President’s border wall, packaging it with the seven remaining FY 2019 spending bills, which include funding for the Food and Drug Administration (FDA) and the National Science Foundation (NSF). I am feeling optimistic about a deal being struck, not least because Sen. Richard Shelby (R-AL), Chairman of the Senate Appropriations Committee, and Representative Nita Lowey (D-NY), Chairwoman of the House Appropriations Committee, are leading the congressional...
Continue Reading

Mary Woolley's Weekly Letter: Walking the priority talk

By Mary Woolley on January 24, 2019
Dear Research Advocate: The impact of the partial government shutdown – now entering its second month – continues to reverberate across the U.S., causing individual suffering and squandering progress at the expense of us all. Research!America signed on to two letters highlighting ways this shutdown is affecting the critical roles of FDA and NSF , not to mention the individuals impacted by their life-saving work. A picture (or graphic) is worth a thousand words: we have been using visuals via Twitter to make the case for ending the shutdown. I hope you’ll retweet and add your own voice to the conversation here . As we continue to push for a resolution to the shutdown, we must also work to...
Continue Reading

Mary Woolley's Weekly Letter: Keep moving

By Mary Woolley on January 17, 2019
Dear Research Advocate, The partial government shutdown continues, now at day 27. There are too many furloughed workers struggling to make ends meet, our nation’s parks and monuments are being ruined, research support by NSF has been put on hold, and drug approvals have slowed at FDA. For a run-down on the broadscale impact, see this USA Today article quoting ASBMB’s Ben Corb, and for a closer look at the toll the shutdown is taking on research, check out this article discussing the impact at the University of Wisconsin, emblematic of so many campuses nationwide. As a temporary patch, agency leaders have called back thousands of employees to work without pay. At the FDA, Commissioner Scott...
Continue Reading

Mary Woolley's Weekly Letter: Positioning the US for success

By Mary Woolley on January 10, 2019
Dear Research Advocate: The government remains in a partial shutdown that began on December 22, taking a mounting toll on 800,000 federal workers, including those at FDA and NSF. The Alliance for a Stronger FDA has put together a “ Shutdown Toolkit ” detailing how this ongoing impasse is affecting us all. In a similar vein, the Coalition for National Science Funding has been sharing stories on social media that focus on how the shutdown is impacting NSF-funded research and programs, stifling discovery and sending a message of ‘no public confidence’ to aspiring young scientists. Clearly, the effects of the shutdown on research are multiple, disruptive and counterproductive. This New York...
Continue Reading

Mary Woolley's Weekly Letter: Advocacy works in the new year!

By Mary Woolley on January 3, 2019
Dear Research Advocate: In welcome news, last night the (departing) 115th Senate voted to confirm Dr. Kelvin Droegemeier as Director of the White House Office of Science and Technology Policy (OSTP). Research!America sent a thank you note acknowledging the roles Senate Commerce Committee leaders John Thune (R-SD) and Bill Nelson (D-FL) played in advancing the nomination. This confirmation is a great beginning for the new year – and the most recent evidence that advocacy works! Tomorrow marks Research!America’s 30th anniversary. There is no question that over three decades, the medical and health research advocacy community has become more organized and more effective. While our community...
Continue Reading

Twitter

Tags

21st Century Cures advocacy Advocacy Awards AHRQ Alzheimer's biomedical research Campaign for Cures cancer CDC FDA Francis Collins global health health research innovation Mary Woolley medical progress medical research mental health National Health Research Forum National Institutes of Health NIH NSF public health Public Health Thank You Day research Research!America science sequestration weekly letter weekly message
More

Blogroll

Previous Posts

March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016

Take Action

 

Contact Congress

 

Get Informed

 

Become a Member

 

Make a Donation

How Can I Help?

Don't leave advocacy to others: sign up for our advocacy alerts and send a message through our website.

Other Advocacy Tools:

Sidebar Quote

Without continued support for health research, many of the most promising young scientists, their ideas and a myriad of potentially life-changing scientific breakthroughs will vanish into oblivion.
Paul Marinec, PhD; University of California San Francisco